Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

BACLOFEN 5 MG TABLET

baclofen
$0.0789per EA

Strength

5 mg/1

Manufacturer

Lannett Company Inc.

NDC

00527133301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

BACLOFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA077241

On Market Since

9/22/2021

Pharmacological Classes

GABA A Agonists
GABA B Agonists
gamma-Aminobutyric Acid-ergic Agonist

Price History

1W

0.0%

1M

-7.3%

3M

-15.4%

6M

-23.0%

1Y

-17.8%

3Y

-62.3%

5Y

N/A

All

-72.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

ZOLPIDEM TARTRATE 10 MG TABLET
Generic
65862016005•Aurobindo Pharma Limited
$0.0271
per EA
ZOLPIDEM TARTRATE 5 MG TABLET
Generic
65862015905•Aurobindo Pharma Limited
$0.0294
per EA
BACLOFEN 10 MG TABLET
Generic
63739047910•McKesson
$0.0329
per EA
BACLOFEN 10 MG TABLET
Generic
00172409660•Teva Pharmaceuticals USA Inc.
$0.0340
per EA
BACLOFEN 10 MG TABLET
Generic
00172409680•Teva Pharmaceuticals USA Inc.
$0.0340
per EA
BACLOFEN 10 MG TABLET
Generic
00603240621•Endo USA Inc.
$0.0340
per EA
BACLOFEN 10 MG TABLET
Generic
00603240628•Endo USA Inc.
$0.0340
per EA
BACLOFEN 10 MG TABLET
Generic
00603240632•Endo USA Inc.
$0.0340
per EA
BACLOFEN 10 MG TABLET
Generic
00832105410•Upsher-Smith Laboratories LLC
$0.0340
per EA
BACLOFEN 10 MG TABLET
Generic
00832105411•Upsher-Smith Laboratories LLC
$0.0340
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy